TDRD7 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.349600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.153200E-01
Normal-vs-Stage2
9.562600E-01
Normal-vs-Stage3
2.624000E-02
Normal-vs-Stage4
7.759400E-01
Stage1-vs-Stage2
7.954600E-01
Stage1-vs-Stage3
1.333800E-01
Stage1-vs-Stage4
6.100200E-01
Stage2-vs-Stage3
5.350400E-02
Stage2-vs-Stage4
6.043600E-01
Stage3-vs-Stage4
1.218370E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.009400E-01
Normal-vs-AfricanAmerican
9.990200E-01
Normal-vs-Asian
5.670000E-01
Caucasian-vs-AfricanAmerican
8.634800E-01
Caucasian-vs-Asian
1.743850E-01
AfricanAmerican-vs-Asian
4.881600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.834800E-01
Normal-vs-Female
8.613600E-01
Male-vs-Female
5.620600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.813220E-01
Normal-vs-Age(41-60Yrs)
6.771000E-01
Normal-vs-Age(61-80Yrs)
7.078800E-01
Normal-vs-Age(81-100Yrs)
6.070200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.187000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.957200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.059600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
8.544500E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.241970E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.825600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.409800E-01
Normal-vs-Daily Drinker
8.505600E-01
Normal-vs-Weekly Drinker
5.515000E-01
Normal-vs-Occasional Drinker
7.131000E-01
Normal-vs-Social Drinker
8.913800E-01
Non Drinker-vs-Daily Drinker
6.314300E-02
Non Drinker-vs-Weekly Drinker
9.348600E-01
Non Drinker-vs-Occasional Drinker
3.291800E-02
Non Drinker-vs-Social Drinker
1.853590E-01
Daily Drinker-vs-Weekly Drinker
1.827820E-01
Daily Drinker-vs-Occasional Drinker
6.995200E-01
Daily Drinker-vs-Social Drinker
5.773200E-01
Weekly Drinker-vs-Occasional Drinker
1.221640E-01
Weekly Drinker-vs-Social Drinker
3.246600E-01
Occasional Drinker-vs-Social Drinker
3.408800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.537700E-02
Normal-vs-Grade 2
2.874100E-02
Normal-vs-Grade 3
6.035700E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.873200E-01
Grade 1-vs-Grade 3
6.871600E-01
Grade 1-vs-Grade 4
3.537700E-02
Grade 2-vs-Grade 3
6.548000E-01
Grade 2-vs-Grade 4
2.874100E-02
Grade 3-vs-Grade 4
6.035700E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.800200E-01
Normal-vs-NonDiabetic
9.875400E-01
Diabetic-vs-NonDiabetic
1.470840E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
9.025000E-01
Normal-vs-NoPancreatitis
8.743000E-01
Pancreatitis-vs-NoPancreatitis
5.995400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.414800E-01
Normal-vs-N1
9.543200E-01
N0-vs-N1
6.922800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.440800E-01
Normal-vs-TP53-NonMutant
9.151400E-01
TP53-Mutant-vs-TP53-NonMutant
2.121000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
